Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. White · SciRah

Researcher profile · Semantic Scholar

E. White

Share profile

E. White — researcher profile on SciRah

h-index: 11
Works: 26
Citations: 642

Most-cited papers

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children
A. Turkova, E. White, H. Mujuru, A. Kekitiinwa +41 more
2021New England Journal of Medicine111 citations Open access
Semantic Scholar
Intimate partner violence, depression, and sexual behaviour among gay, bisexual and other men who have sex with men in the PROUD trial
A. Miltz, F. Lampe, L. Bacchus, S. McCormack +9 more
2019BMC Public Health85 citations Open access
Semantic Scholar
Recent trends and patterns in HIV‐1 transmitted drug resistance in the United Kingdom
A. Tostevin, E. White, D. Dunn, S. Croxford +52 more
2016HIV Medicine75 citations Open access
Semantic Scholar
The Context of Sexual Risk Behaviour Among Men Who Have Sex with Men Seeking PrEP, and the Impact of PrEP on Sexual Behaviour
M. Gafos, R. Horne, W. Nutland, G. Bell +17 more
2018Aids and Behavior72 citations Open access
Semantic Scholar
Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment trial
JD Baxter, D. Dunn, E. White, S. Sharma +6 more
2015HIV Medicine65 citations Open access
Semantic Scholar
Chemsex is not a barrier to self-reported daily PrEP adherence among PROUD study participants
Charlotte O'Halloran, B. Rice, E. White, M. Desai +6 more
2019The International journal on drug policy46 citations Open access
Semantic Scholar
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.
S. Lambert-Niclot, E. George, A. Pozniak, E. White +13 more
2016Journal of Antimicrobial Chemotherapy29 citations Open access
Semantic Scholar
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial
P. Amuge, A. Lugemwa, B. Wynne, H. Mujuru +25 more
2022The Lancet HIV28 citations Open access
Semantic Scholar
HIV-1 drug resistance mutations emerging on darunavir therapy in PI-naive and -experienced patients in the UK
K. El Bouzidi, E. White, J. Mbisa, C. Sabin +6 more
2016Journal of Antimicrobial Chemotherapy22 citations Open access
Semantic Scholar
Predictive factors for HIV infection among men who have sex with men and who are seeking PrEP: a secondary analysis of the PROUD trial
E. White, D. Dunn, M. Desai, M. Gafos +4 more
2019Sexually Transmitted Infections18 citations Open access
Semantic Scholar
An association between K65R and HIV-1 subtype C viruses in patients treated with multiple NRTIs
E. Smit, E. White, D. Clark, D. Churchill +9 more
2017Journal of Antimicrobial Chemotherapy13 citations Open access
Semantic Scholar
No Evidence That HIV-1 Subtype C Infection Compromises the Efficacy of Tenofovir-Containing Regimens: Cohort Study in the United Kingdom
E. White, E. Smit, D. Churchill, S. Collins +5 more
2016Journal of Infectious Diseases12 citations Open access
Semantic Scholar
Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial
A. Turkova, E. White, A. Kekitiinwa, V. Mumbiro +25 more
2023The Lancet Child & Adolescent Health11 citations Open access
Semantic Scholar
High incidence of Hepatitis C virus infection observed in the PROUD study of HIV pre‐exposure prophylaxis
M. Desai, E. White, N. Vora, R. Gilson +9 more
2020Journal of Viral Hepatitis11 citations Open access
Semantic Scholar
Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance
A. Geretti, E. White, C. Orkin, Anna Tostevin +5 more
2018Journal of Antimicrobial Chemotherapy8 citations Open access
Semantic Scholar
O016 Renal function at baseline and month 1 in the PROUD study, a pragmatic open label randomised trial of Truvada as Pre-Exposure Prophylaxis
I. Reeves, E. White, E. Brodnicki, D. Dunn +5 more
20168 citations Open access
Semantic Scholar
Prevalence and correlates of depressive symptoms among gay, bisexual and other men who have sex with men in the PROUD randomised clinical trial of HIV pre-exposure prophylaxis
A. Miltz, F. Lampe, S. McCormack, D. Dunn +8 more
2019BMJ Open7 citations Open access
Semantic Scholar
Acceptability of an open-label wait-listed trial design: Experiences from the PROUD PrEP study
M. Gafos, E. Brodnicki, M. Desai, S. McCormack +25 more
2017PLoS ONE7 citations Open access
Semantic Scholar
Long-term follow-up of PROUD: evidence for high continued HIV exposure and durable effectiveness of PrEP
E. White, D. Dunn, R. Gilson, A. Sullivan +14 more
20177 citations
Semantic Scholar
Electronic health records to capture primary outcome measures: two case studies in HIV prevention research
D. Dunn, L. McCabe, E. White, V. Delpech +7 more
2023Trials4 citations Open access
Semantic Scholar
Protease mutations emerging on darunavir in protease inhibitor-naïve and experienced patients in the UK
K. El Bouzidi, E. White, J. Mbisa, A. Phillips +3 more
2014Journal of the International AIDS Society4 citations Open access
Semantic Scholar
Baseline predictors of HIV Infection in the no-PrEP group in the PROUD trial
M. Desai, N. Gill, S. McCormack, D. Dunn +6 more
20162 citations
Semantic Scholar
O03 Impact of prep on sexual behaviour? significantly lower rate of rectal ct in non-prep users in the deferred phase of proud disappeared when everyone had access to prep
A. Sullivan, C. Lacey, E. White, N. Mackie +7 more
2017Sexually Transmitted Infections1 citations Open access
Semantic Scholar
HIV pre-exposure prophylaxis: additional insights through secondary analyses of the PROUD trial
E. White
20200 citations
Semantic Scholar
Antiretroviral resistance at virologic failure in the NEAT 001 / ANRS 143 trial : Raltegravir + 1 Darunavir / ritonavir or Tenofovir / Emtricitabine + Darunavir / ritonavir as first line 2 antiretroviral therapy 3
S. Lambert-Niclot, E. George, A. Pozniak, E. White +14 more
20160 citations
Semantic Scholar
Secondary Prophylaxis Versus On-Demand Treatment in Adult Hemophilia Patients – Increased Factor Use without Increased Benefit?
V. Sharma, E. White, O. Ladipo, A. Cohen
20110 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. McCormack×12
Invite
S. McCormack — researcher profile on SciRah
A. Sullivan×10
Invite
A. Sullivan — researcher profile on SciRah
D. Dunn×9
Invite
D. Dunn — researcher profile on SciRah
A. Clarke×9
Invite
A. Clarke — researcher profile on SciRah

×8

Invite

M. Gafos — researcher profile on SciRah

Invite

D. Dunn — researcher profile on SciRah

Invite

A. Phillips — researcher profile on SciRah

Invite

A. Pozniak — researcher profile on SciRah

Invite

R. Gilson — researcher profile on SciRah

Invite

C. Lacey — researcher profile on SciRah

Invite

I. Reeves — researcher profile on SciRah

Invite

A. Tostevin — researcher profile on SciRah